1932

Abstract

Recent discoveries indicate that gain-of-function mutations in the Notch1 receptor are very common in human T cell acute lymphoblastic leukemia/lymphoma. This review discusses what these mutations have taught us about normal and pathophysiologic Notch1 signaling, and how these insights may lead to new targeted therapies for patients with this aggressive form of cancer.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.pathmechdis.3.121806.154300
2008-02-28
2024-06-15
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.pathmechdis.3.121806.154300
Loading
/content/journals/10.1146/annurev.pathmechdis.3.121806.154300
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error